Novel Rash in a High-Risk HIV-Exposed Infant

Abstract

Get full access to this article

View all access options for this article.

References

Guidelines for the use of antiretroviral agents in pediatric HIV infection. Accessed June 6, 2023. https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv.

Carder

. Hypersensitivity reactions in neonates and infants. Dermatol Ther. 2005;18(2):160-175. doi:10.1111/j.1529-8019.2005.05014.x.

Bardsley-Elliot

Perry

. Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection. Paediatr Drugs. 2000;2(5):373-407. doi:10.2165/00128072-200002050-00005.

Shah

. Adverse effects of antiretroviral therapy in HIV-1 infected children. J Trop Pediatr. 2006;52(4):244-248. doi:10.1093/tropej/fmi086.

Minniear

Zeh

Polle

, et al. Rash, hepatotoxicity and hyperbilirubinemia among Kenyan infants born to HIV-infected women receiving triple-antiretroviral drugs for the prevention of mother-to-child HIV transmission. Pediatr Infect Dis J. 2012;31(11):1155-1157. doi:10.1097/INF.0b013e318267ef6a.

de Waal

Kroon

Holgate

, et al. Nevirapine concentrations in preterm and low birth weight HIV-exposed infants: implications for dosing recommendations. Pediatr Infect Dis J. 2014;33(12):1231-1233. doi:10.1097/INF.0000000000000453.